Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.


  • Repeating aloud to another person boosts recall

  • American placebo: New analysis of chronic pain drug trials shows increasing placebo responses over time, in the US only

  • Understanding others' thoughts enables young kids to lie

  • Mutation involved in neurodegeneration discovered

  • How dominant parents affect kids' self-worth

  • Virus-drug combination shows improved effectiveness against brain tumor cells

  • Risk profiling is key to managing pain in era of opioid abuse

  • Benzodiazepines ineffective in treating anxiety disorders may increase dementia risk

  • Immigrants play increasing role in U.S. science, engineering workforce

  • Scientists identify how normally protective immune responses kill neurons